NCT00609349

Brief Summary

The early detection of pulmonary arterial hypertension may help to improve prognosis of the disease. It is assumed that in the early stages of pulmonary arterial hypertension, pulmonary arterial pressure values may be normal at rest, but the remodelling of small arteries leads to stiffening resulting in increased pulmonary arterial pressure during exercise. In the present study we investigate patients with risk factors for pulmonary arterial hypertension (e.g. connective tissue disease) by combining exercise tricuspid echo doppler and cardiopulmonary exercise test to screen patients for exercise-induced pulmonary hypertension and control the results by the gold standard right heart catheterisation at rest and during exercise. We expect that using this screening method, patients with pulmonary arterial hypertension would be recognized earlier.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2006

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2006

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

January 24, 2008

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 7, 2008

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
Last Updated

January 12, 2012

Status Verified

January 1, 2012

Enrollment Period

3.1 years

First QC Date

January 24, 2008

Last Update Submit

January 11, 2012

Conditions

Keywords

risk factors for pulmonary arterial hypertension

Outcome Measures

Primary Outcomes (1)

  • pulmonary arterial pressure

    measurements with right heart catheterisation within 1 month after exercise tricuspid doppler

Secondary Outcomes (1)

  • exercise capacity (peakVO2, 6 minute walk distance)

    controlled at 1 year after baseline

Study Arms (1)

connective tissue disease

OTHER

all patients suffer from a connective tissue disease representing a risk for the development of pulmonary hypertension

Device: ETED, CPET, RHC

Interventions

exercise tricuspid echo doppler (ETED): allows the estimation of systolic pulmonary arterial pressure at exercise cardiopulmonary exercise test (CPET) allows to measures exercise capacity (peakVO2) right heart catheterisation (RHC): is the gold standard for the measurement of pulmonary arterial pressure values

connective tissue disease

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Systemic sclerosis
  • SLE
  • Late corrected left-right shunt
  • HIV Infection
  • Splenectomy over 10 years
  • Haemoglobinopathy and Thrombocytosis
  • Ventriculo-atrial Shunt
  • Liver cirrhosis/other portal Hypertension
  • Anamnestic Aminorex or PhenFen abuse
  • Close relatives of patients with IPAH
  • Healthy controls

You may not qualify if:

  • Known PAH
  • Severe lung or bronchial disease (FEV1 \<70% predicted)
  • Systolic LV dysfunction (LVEF \<50%) or diastolic dysfunction (pulmonary arterial "wedge" pressure (PAWP) ≥15 mmHg)
  • Valvular dysfunction \> Grad I (except of Tricuspidal- and Pulmonary insufficiency)
  • Uncontrolled systemic arterial hypertension (rest \>150 mmHg systolic or 90 mmHg diastolic; exercise \>220 mmHg systolic)
  • Uncontrolled ventricular arrythmia
  • Uncontrolled supraventricular arrythmia
  • Myocardial infarction within last 12 months
  • Pulmonary embolism within last 12 months
  • Significant change in therapy or larger operation within last 12 weeks
  • Inability of performing exercise on cycle ergometer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University Graz, Division of Pulmonology

Graz, Styria, 8036, Austria

Location

Related Publications (2)

  • Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Hesse C, Troester N, Salmhofer W, Stauber R, Fuerst FC, Thonhofer R, Ofner-Kopeinig P, Gruenig E, Olschewski H. Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization. Chest. 2010 Aug;138(2):270-8. doi: 10.1378/chest.09-2099. Epub 2010 Apr 23.

  • Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Troster N, Hesse C, Salmhofer W, Graninger W, Gruenig E, Rubin LJ, Olschewski H. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med. 2009 Nov 1;180(9):881-6. doi: 10.1164/rccm.200904-0563OC. Epub 2009 Aug 13.

MeSH Terms

Conditions

Pulmonary Arterial Hypertension

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Hypertension, PulmonaryLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Horst Olschewski, MD

    Medical University of Graz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2008

First Posted

February 7, 2008

Study Start

April 1, 2006

Primary Completion

May 1, 2009

Study Completion

May 1, 2009

Last Updated

January 12, 2012

Record last verified: 2012-01

Locations